Related Experiment Video
Updated: Aug 7, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
Abstract:
Using age-specific rates for multiple sclerosis (MS) based on a national survey, the number of "naturally occurring" new cases of MS among the 45 million swine flu vaccine recipients in the United States is estimated as 1,624 during the year after vaccination, or 31 cases per week. Information from available reports and publications indicates no excess over the expected frequencies. Analyses of admissions for MS before, during, and after the immunization program showed no increase to the US Army hospitals or to the Mayo Clinic. Three independent controlled clinical investigations performed on patients with MS showed no increase in the frequency of exacerbations among those receiving swine flu vaccine as compared with those receiving placebo. Epidemiologic features of MS do not implicate killed virus vaccine as an etiologic factor in onset or exacerbations of the disease. There is no indication from these analyses of any association or cause-and-effect relationship between swine flu vaccine and MS.
Insights
The 1976 swine flu vaccine did not increase the risk of developing multiple sclerosis (MS). Studies found no excess MS cases or exacerbations linked to the vaccine, indicating no causal relationship.
Area of Science:
- Epidemiology
- Immunology
- Neurology
Background:
- Concerns arose regarding a potential link between the 1976 swine flu vaccine and multiple sclerosis (MS).
- Previous analyses did not establish an association between vaccination and MS onset or exacerbations.
Purpose of the Study:
- To estimate the number of new multiple sclerosis cases following swine flu vaccination.
- To investigate potential associations between swine flu vaccination and MS incidence or exacerbations.
Main Methods:
- Utilized age-specific rates from national surveys to estimate expected MS cases in vaccine recipients.
- Analyzed hospital admission data before, during, and after the swine flu immunization program.
- Reviewed findings from three independent controlled clinical trials comparing vaccine and placebo groups.
Main Results:
- An estimated 1,624 new multiple sclerosis cases were expected among 45 million swine flu vaccine recipients.
- No excess frequency of MS cases or exacerbations was observed compared to expected rates or placebo groups.
- Analyses of US Army hospitals and Mayo Clinic data showed no increase in MS admissions.
Conclusions:
- The 1976 swine flu vaccine is not implicated as an etiologic factor in the onset or exacerbation of multiple sclerosis.
- Epidemiological data and clinical investigations indicate no association or cause-and-effect relationship between swine flu vaccine and MS.
More Related Videos
Related Concept Videos
Viral Recombination
Cross-reactivity
Vaccinations
Poliomyelitis
Respiratory Syncytial Virus Disease
Multiple Sclerosis l: Introduction

